Royal Bank of Canada’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
471,607
+468,933
| +17,537% | +$1.28M | ﹤0.01% | 3376 |
|
|
2025
Q1 | $4K | Sell |
2,674
-4,318
| -62% | -$6.46K | ﹤0.01% | 6042 |
|
|
2024
Q4 | $11K | Sell |
6,992
-10,818
| -61% | -$17K | ﹤0.01% | 5830 |
|
|
2024
Q3 | $74K | Buy |
17,810
+4,975
| +39% | +$20.7K | ﹤0.01% | 5058 |
|
|
2024
Q2 | $70K | Buy |
12,835
+5,766
| +82% | +$31.4K | ﹤0.01% | 5105 |
|
|
2024
Q1 | $70K | Sell |
7,069
-24,419
| -78% | -$242K | ﹤0.01% | 4937 |
|
|
2023
Q4 | $129K | Buy |
31,488
+15,522
| +97% | +$63.6K | ﹤0.01% | 4929 |
|
|
2023
Q3 | $61K | Buy |
15,966
+6,229
| +64% | +$23.8K | ﹤0.01% | 5191 |
|
|
2023
Q2 | $58K | Buy |
9,737
+4,157
| +74% | +$24.8K | ﹤0.01% | 5258 |
|
|
2023
Q1 | $18K | Sell |
5,580
-6,025
| -52% | -$19.4K | ﹤0.01% | 5683 |
|
|
2022
Q4 | $47K | Buy |
11,605
+10,195
| +723% | +$41.3K | ﹤0.01% | 5456 |
|
|
2022
Q3 | $9K | Buy |
1,410
+559
| +66% | +$3.57K | ﹤0.01% | 5991 |
|
|
2022
Q2 | $5K | Sell |
851
-4,754
| -85% | -$27.9K | ﹤0.01% | 6198 |
|
|
2022
Q1 | $46K | Sell |
5,605
-14,877
| -73% | -$122K | ﹤0.01% | 5674 |
|
|
2021
Q4 | $317K | Buy |
20,482
+10,377
| +103% | +$161K | ﹤0.01% | 4370 |
|
|
2021
Q3 | $227K | Buy |
10,105
+8,066
| +396% | +$181K | ﹤0.01% | 4559 |
|
|
2021
Q2 | $40K | Buy |
2,039
+1,898
| +1,346% | +$37.2K | ﹤0.01% | 5690 |
|
|
2021
Q1 | $5K | Buy |
+141
| New | +$5K | ﹤0.01% | 6549 |
|